Medical device company, St. Jude Medical Inc. (STJ), recently enrolled the first patient in the STAR-VT (Substrate Targeted Ablation using the FlexAbility Ablation Catheter System for the Reduction of Ventricular Tachycardia) clinical trial.
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1w3Ymd6
via IFTTT
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1w3Ymd6
via IFTTT
No comments:
Post a Comment